4

OWNERSHIP DOCUMENT

Company: Acurx Pharmaceuticals, Inc.
Filed: July 29, 2022
Period of Report: July 27, 2022
Accession Number: 0001104659-22-084316

View Document ↗ View on SEC.gov ↗